As a result, we targeted LCN-2 to study the molecular mechanism of MCDD in improving PCOS-IR by regulating NF-κB/LCN-2 signaling in the inflammatory microenvironment. This evidence concerns the gene NFKB1 and polycystic ovary syndrome.